Articles dans des revues avec comité de lecture (42)
37.
Vouche, M., Vanderlinden, B., Delatte, P., Lemort, M., Hendlisz, A., Deleporte, A., Guiot, T., Garcia, C., & Flamen, P. (2011). New Imaging Techniques for 90Y Microsphere Radioembolization. The Journal of nuclear medicine, 2, 113. doi:10.4172/2155-9619.100011338.
Huyge, V., Garcia, C., Alexiou, J., Ameye, L., Vanderlinden, B., Lemort, M., Bergmann, P., Awada, A., Body, J.-J., & Flamen, P. (2010). Heterogeneity of metabolic response to systemic therapy in metastatic breast cancer patients. Clinical oncology, 22(10), 818-827. doi:10.1016/j.clon.2010.05.02139.
Woff, E., Garcia, C., Tant, L., Muylle, K., Ghanem, G. E., Bourgeois, P., & Flamen, P. (2010). Imaging of tumour-induced osteomalacia using a gallium-68 labelled somatostatin analogue. BMJ case reports. doi:10.1136/bcr.02.2010.275040.
Huyge, V., Garcia, C., Vanderstappen, A., Alexiou, J., Gil, T., & Flamen, P. (2009). Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET. Clinical nuclear medicine, 34(7), 417-420. doi:10.1097/RLU.0b013e3181a7d03c42.
Laique, S., Egrise, D., Monclus, M., Schmitz, F., Garcia, C., Lemaire, C., Luxen, A., & Goldman, S. (2006). L-amino acid load to enhance PET differentiation between tumor and inflammation: an in vitro study on (18)F-FET uptake. Contrast Media & Molecular Imaging, 1(5), 212-220. doi:10.1002/cmmi.107 Communications publiées lors de congrès ou colloques nationaux et internationaux (6)
1.
Paesmans, M., Wong, C., Patz, E., Komaki, R., Eschmann, S., Govidan, R., Vansteenkiste, J., Meert, A.-P., de Jong, W., Higashi, K., Borst, G., Van Baardwijk, A., Ameye, L., Lafitte, J.-J., Berghmans, T., Garcia, C., Flamen, P., Rami Porta, R., & Sculier, J.-P. (2011). Is primary tumour standardized uptake value (SUV) an independent prognostic factor for non small cell lung cancer (NSCLC)?: A meta-analysis based on individual data. European Respiratory Society Annual Congress (2011: Amsterdam, The Netherlands)2.
Garcia, C., Terrones Munoz, V., Sculier, J.-P., Flamen, P., & Berghmans, T. (2010). Are Primary Tumour Standardized Uptake Value (PT SUVmax), Total lesion glycolysis (TLG) and metabolic volume (MV) measured on FDG PET(CT) predictors of survival in advanced Non-Small Cell Lung Cancer (NSCLC)? 2010 World Molecular Imaging Congress (September 8-11, 2010: Kyoto, Japan)3.
Terrones Munoz, V., Garcia, C., Flament, P., Meert, A.-P., CsToth, I., Sculier, J.-P., & Berghmans, T. (2010). Are primary tumour standardized uptake value (PT SUVmax), total lesion glycolysis (TLG) and metabolic volume (MV) measured on FDG PET(CT) predictors of survival in non-small cell lung cancer (NSCLC) ? 35th ESMO Congress (2010: Milano, Italy)4.
Berghmans, T., Paesmans, M., Dusart, M., Garcia, C., Hossein-Foucher, C., Lafitte, J.-J., Mascaux, C., Meert, A.-P., Roelandts, M., Scherpereel, A., Terrones Munoz, V., & Sculier, J.-P. (2009). An updated meta-analysis (MA) of the literature assessing the prognostic role of primary tumour standardized uptake value (SUV) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) in non-small cell lung cancer (NSCLC). 13th World Conference on Lung Cancer (San Francisco, USA)5.
Van Ruychevelt, V., Garcia, C., Paesmans, M., Berghmans, T., Meert, A.-P., Leclercq, N., Flament, P., & Sculier, J.-P. (2009). Assessing response to chemotherapy in advanced non small cell lung cancer (NSCLC): morphological or metabolic criteria ? 13th World Conference on Lung Cancer (San Francisco, USA)6.
Akouaouach, H., Garcia, C., Paternot, J., Bergmann, P., Pepersack, T., Gheldof, R., & Beyer, I. (2006). Evaluation of sarcopenia by the measurement of total body potassium in a hospitalized geriatric cohort. International Association for Gerontology (17-19/02/06: Oostende)